RTIYU Trademark

Trademark Overview


On Wednesday, December 9, 2020, a trademark application was filed for RTIYU with the United States Patent and Trademark Office. The USPTO has given the RTIYU trademark a serial number of 90369620. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 2, 2023. This trademark is owned by Hikma Pharmaceuticals USA Inc.. The RTIYU trademark is filed in the Pharmaceutical Products category with the following description:

syringes, vials, bags, auto-injectors, sublingual drug delivery devices, and intranasal drug delivery devices, all prefilled with pharmaceutical preparations and substances, namely, systemic anti-infectives, pharmaceutical and medicinal substances for the prevention, curing, and treatment of viral, metabolic, alimentary, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, parasitic, psychiatric, and immune system related diseases and disorders; pharmaceutical and medicinal substances for the prevention, curing, and treatment of allergies, inflammation, pain, infectious diseases, blood diseases and disorders, nervous system diseases and disorders, malignant neoplastic diseases and disorders, and immunomodulating agent diseases and disorders
rtiyu

General Information


Serial Number90369620
Word MarkRTIYU
Filing DateWednesday, December 9, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 2, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 6, 2021

Trademark Statements


Goods and Servicessyringes, vials, bags, auto-injectors, sublingual drug delivery devices, and intranasal drug delivery devices, all prefilled with pharmaceutical preparations and substances, namely, systemic anti-infectives, pharmaceutical and medicinal substances for the prevention, curing, and treatment of viral, metabolic, alimentary, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, parasitic, psychiatric, and immune system related diseases and disorders; pharmaceutical and medicinal substances for the prevention, curing, and treatment of allergies, inflammation, pain, infectious diseases, blood diseases and disorders, nervous system diseases and disorders, malignant neoplastic diseases and disorders, and immunomodulating agent diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHikma Pharmaceuticals USA Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBerkeley Heights, NJ 07922

Party NameHikma Pharmaceuticals USA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerkeley Heights, NJ 07922

Trademark Events


Event DateEvent Description
Monday, October 2, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 2, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 27, 2023SOU EXTENSION 3 GRANTED
Monday, February 27, 2023SOU EXTENSION 3 FILED
Monday, February 27, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 16, 2022SOU EXTENSION 2 GRANTED
Tuesday, August 16, 2022SOU EXTENSION 2 FILED
Tuesday, August 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 14, 2022SOU EXTENSION 1 GRANTED
Monday, February 14, 2022SOU EXTENSION 1 FILED
Monday, February 14, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 31, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 6, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 16, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 29, 2021ASSIGNED TO EXAMINER
Tuesday, February 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 12, 2020NEW APPLICATION ENTERED